Logo.jpg
Immunotherapy Drugs Market To Reach USD 235.4 Billion By 2032, Says DataHorizzon Research
12 oct. 2023 08h10 HE | DataHorizzon Research
Fort Collins, Colorado, Oct. 12, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the immunotherapy drugs market size was valued at USD 121.5 Billion in 2022 and is expected to reach USD...
logo.png
Immunotherapy Drugs Market Size to Surpass US$ 351.56 BN by 2030
30 nov. 2022 09h51 HE | Precedence Research
Ottawa, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The immunotherapy drugs market size was estimated at USD 190.44 billion in 2022. The rising prevalence of various chronic diseases among the global...
fior-markets-logo.jpg
Immunotherapy Drug Market to Set a High Potential Growth of USD 415.76 billion by 2027 : Fior Markets
19 mai 2022 12h00 HE | Fior Markets
Newark, NJ, May 19, 2022 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, The global immunotherapy drug market is expected to grow from USD 156.39 billion in 2019 to USD 415.76...
zion_logo_150x150.jpg
Global Immunotherapy Drugs Market Expected to Reach USD 330.4 Billion By 2025: Zion Market Research
29 janv. 2019 06h58 HE | Zion Market Research
New York, NY, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Immunotherapy Drugs Market by Drug Type (Adult Vaccines, Monoclonal Antibodies, Checkpoint...
P&S-Intelligence..jpg
Immunotherapy Drugs Market Size to Reach $227.6 Billion by 2023: P&S Intelligence
05 déc. 2018 01h30 HE | Prescient & Strategic Intelligence
Immunotherapy Drugs Market by Type (Checkpoint Inhibitors [Brand {Humira, Rituxan/MabThera, Herceptin, Remicade, Enbrel}], Vaccines [Type {Preventive, Therapeutic}, Brand {Prevnar/Prevenar 13,...